This interaction reduces the miRNA silencing activity toward its downstream targets, i.e., the mRNAs coding for GLUT1, NRP1, YY1, and Wnt5a, thus contributing to oncogenic pathways driving lung cancer (Figure 6). The gene discussed is SLC2A1; the disease is lung cancer.